rs368758031
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1PM2
The NM_021098.3(CACNA1H):c.1371C>A(p.Tyr457*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000007 in 1,429,156 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Synonymous variant affecting the same amino acid position (i.e. Y457Y) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_021098.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.1371C>A | p.Tyr457* | stop_gained | Exon 9 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.1371C>A | p.Tyr457* | stop_gained | Exon 9 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.1371C>A | p.Tyr457* | stop_gained | Exon 9 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.1371C>A | p.Tyr457* | stop_gained | Exon 9 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.1371C>A | p.Tyr457* | stop_gained | Exon 9 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.1371C>A | p.Tyr457* | stop_gained | Exon 9 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.1332C>A | p.Tyr444* | stop_gained | Exon 9 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.1371C>A | p.Tyr457* | stop_gained | Exon 9 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.1332C>A | p.Tyr444* | stop_gained | Exon 9 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.1371C>A | p.Tyr457* | stop_gained | Exon 9 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.1371C>A | p.Tyr457* | stop_gained | Exon 9 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.1371C>A | p.Tyr457* | stop_gained | Exon 9 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1 | c.1371C>A | p.Tyr457* | stop_gained | Exon 9 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1 | c.1371C>A | p.Tyr457* | stop_gained | Exon 9 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2 | n.1371C>A | non_coding_transcript_exon_variant | Exon 9 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.1371C>A | non_coding_transcript_exon_variant | Exon 9 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.1371C>A | non_coding_transcript_exon_variant | Exon 9 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.1371C>A | non_coding_transcript_exon_variant | Exon 9 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*818C>A | non_coding_transcript_exon_variant | Exon 8 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.1371C>A | non_coding_transcript_exon_variant | Exon 9 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.1371C>A | non_coding_transcript_exon_variant | Exon 9 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.1371C>A | non_coding_transcript_exon_variant | Exon 9 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.1371C>A | non_coding_transcript_exon_variant | Exon 9 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.1371C>A | non_coding_transcript_exon_variant | Exon 9 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.1371C>A | non_coding_transcript_exon_variant | Exon 9 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.1371C>A | non_coding_transcript_exon_variant | Exon 9 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.1371C>A | non_coding_transcript_exon_variant | Exon 9 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.1371C>A | non_coding_transcript_exon_variant | Exon 9 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000711442.1 | n.*818C>A | 3_prime_UTR_variant | Exon 8 of 34 | ENSP00000518758.1 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome AF: 7.00e-7 AC: 1AN: 1429156Hom.: 0 Cov.: 36 AF XY: 0.00000141 AC XY: 1AN XY: 707872 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome Cov.: 34
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at